Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaAnthony T C Chan, Mow-Ming Hsu, Boon C Goh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography resultsTony S K Mok, Winnie Yeo, Simon Yu, et al.Medicine|March 6, 2016
Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care: Systematic Review and Meta-AnalysisCharlotte H Y Lau, Xinyin Wu, Vincent C H Chung, et al.BMC Cancer|January 6, 2017
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life dataLeung Li, Frankie Kf Mo, Stephen L Chan, et al.Clinical Chemistry|March 20, 2020
Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant ProfilesW K Jacky Lam, Lu Ji, O Y Olivia Tse, et al.International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 TrialXu Liu, Ling Guo, Fang-Yun Xie, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.BMC Cancer|May 13, 2015
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for responseWinnie Yeo, Stephen L Chan, Frankie K F Mo, et al.Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.European Radiology|March 24, 2019
Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRIQi-Yong Ai, Ann D King, Janet S M Chan, et al.Pageof 11